317 related articles for article (PubMed ID: 7987834)
1. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis.
Mangues R; Kahn JM; Seidman I; Pellicer A
Cancer Res; 1994 Dec; 54(24):6395-401. PubMed ID: 7987834
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of lymphomagenesis by methylnitrosourea in mice transgenic for LMO1 is blocked by O6-alkylguanine DNA-alkyltransferase.
Allay E; Reese JS; McGuire EA; Koç ON; Sedransk N; Gerson SL
Oncogene; 1997 Oct; 15(17):2127-32. PubMed ID: 9366529
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
4. Activated N-ras oncogene and N-ras proto-oncogene act through the same pathway for in vivo tumorigenesis.
Mangues R; Symmans WF; Lu S; Schwartz S; Pellicer A
Oncogene; 1996 Sep; 13(5):1053-63. PubMed ID: 8806695
[TBL] [Abstract][Full Text] [Related]
5. Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes.
Ando K; Saitoh A; Hino O; Takahashi R; Kimura M; Katsuki M
Cancer Res; 1992 Feb; 52(4):978-82. PubMed ID: 1737360
[TBL] [Abstract][Full Text] [Related]
6. Lung tumorigenesis associated with erb-B-2 and erb-B-3 overexpression in human erb-B-3 transgenic mice is enhanced by methylnitrosourea.
Zhou H; Liu L; Lee K; Qin X; Grasso AW; Kung HJ; Willis JE; Kern J; Wagner T; Gerson SL
Oncogene; 2002 Dec; 21(57):8732-40. PubMed ID: 12483526
[TBL] [Abstract][Full Text] [Related]
7. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea.
Allay E; Veigl M; Gerson SL
Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice.
Reese JS; Allay E; Gerson SL
Oncogene; 2001 Aug; 20(38):5258-63. PubMed ID: 11536039
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice.
Mangues R; Corral T; Kohl NE; Symmans WF; Lu S; Malumbres M; Gibbs JB; Oliff A; Pellicer A
Cancer Res; 1998 Mar; 58(6):1253-9. PubMed ID: 9515813
[TBL] [Abstract][Full Text] [Related]
10. Incidence of c-Ki-ras activation in N-methyl-N-nitrosourea-induced mammary carcinomas in pituitary-isografted mice.
Guzman RC; Osborn RC; Swanson SM; Sakthivel R; Hwang SI; Miyamoto S; Nandi S
Cancer Res; 1992 Oct; 52(20):5732-7. PubMed ID: 1394197
[TBL] [Abstract][Full Text] [Related]
11. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice.
Mangues R; Seidman I; Gordon JW; Pellicer A
Oncogene; 1992 Oct; 7(10):2073-6. PubMed ID: 1328989
[TBL] [Abstract][Full Text] [Related]
14. NF1 inactivation cooperates with N-ras in in vivo lymphogenesis activating Erk by a mechanism independent of its Ras-GTPase accelerating activity.
Mangues R; Corral T; Lu S; Symmans WF; Liu L; Pellicer A
Oncogene; 1998 Oct; 17(13):1705-16. PubMed ID: 9796699
[TBL] [Abstract][Full Text] [Related]
15. A transgenic mouse model for mammary carcinogenesis.
Li B; Murphy KL; Laucirica R; Kittrell F; Medina D; Rosen JM
Oncogene; 1998 Feb; 16(8):997-1007. PubMed ID: 9519874
[TBL] [Abstract][Full Text] [Related]
16. ras oncogenes and phenotypic staging in N-methylnitrosourea- and gamma-irradiation-induced thymic lymphomas in C57BL/6J mice.
Newcomb EW; Steinberg JJ; Pellicer A
Cancer Res; 1988 Oct; 48(19):5514-21. PubMed ID: 3046741
[TBL] [Abstract][Full Text] [Related]
17. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
[TBL] [Abstract][Full Text] [Related]
18. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.
Kumar R; Medina D; Sukumar S
Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247
[TBL] [Abstract][Full Text] [Related]
19. Absence of p53 mutations in methylnitrosourea-induced mammary tumors in rats.
Ogawa K; Tokusashi Y; Fukuda I
Cancer Detect Prev; 1996; 20(3):214-7. PubMed ID: 8769715
[TBL] [Abstract][Full Text] [Related]
20. K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke.
Yao R; Wang Y; D'Agostini F; Izzotti A; Lubet RA; You M; De Flora S
Exp Lung Res; 2005 Mar; 31(2):271-81. PubMed ID: 15824025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
